- ASCO® 2024
- Yale Cancer Answers
- ASH CME Series
- Smilow Shares with Primary Care
- Grand Rounds
- Head and Neck
- Gynecologic
- Benign Hematology
- Breast
- GI
- Lung
- GU
- Hematologic Oncology
- Brain
- Cancer Screening
- DEI (Diversity, Equity and Inclusion)
- 2021 ASH Highlights
- General Events
- Events
Playback speed
10 seconds
Challenges to Precision Medicine for Anti-Cancer Immunotherapy: When Other Combos w/ Anti-PD-1 Are Active, Mechanisms May Be Redundant w anti-CTLA-4
1,041 views
November 28, 2019
Comments 2
Login to view comments.
Click here to Login
Yale Cancer Center Immuno-Oncology Symposium 2019